(Q30936896)

27 June 2017

1 reference

title

Pharmacotherapy of alcohol dependence: a review of the clinical data (English)

1 reference

27 June 2017

0 references

1 reference

Karl Mann

1

1 reference

27 June 2017

publication date

1 January 2004

1 reference

27 June 2017

1 reference

27 June 2017

volume

18

1 reference

27 June 2017

issue

8

1 reference

27 June 2017

page(s)

485-504

1 reference

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

27 June 2017

cites work

1 reference

12 December 2020

Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems.

1 reference

12 December 2020

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

1 reference

12 December 2020

Sustained-release naltrexone for alcoholism treatment: a preliminary study

1 reference

12 December 2020

Acamprosate appears to decrease alcohol intake in weaned alcoholics

1 reference

12 December 2020

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

1 reference

12 December 2020

The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group

1 reference

12 December 2020

Naltrexone and alcohol dependence. Role of subject compliance

1 reference

12 December 2020

Drug therapy for alcohol dependence

1 reference

12 December 2020

Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study

1 reference

12 December 2020

Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes

1 reference

12 December 2020

Pharmacological treatment of alcohol dependence: a review of the evidence

1 reference

12 December 2020

[Does acamprosate diminish the appetite for alcohol in weaned alcoholics?]

1 reference

12 December 2020

Buspirone in the treatment of alcoholic patients.

1 reference

12 December 2020

Naltrexone for alcohol dependence: a randomized controlled trial

1 reference

12 December 2020

Efficacy of buspirone in alcohol dependence: a review

1 reference

12 December 2020

A placebo-controlled trial of buspirone in anxious inpatient alcoholics

1 reference

12 December 2020

Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study

1 reference

12 December 2020

A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression

1 reference

12 December 2020

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

1 reference

12 December 2020

Placebo-controlled study of sertraline in depressed recently abstinent alcoholics

1 reference

12 December 2020

Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group

1 reference

12 December 2020

Naltrexone as an adjunctive treatment for older patients with alcohol dependence

1 reference

12 December 2020

Neurocircuitry targets in ethanol reward and dependence

1 reference

12 December 2020

Safety issues concerning the use of disulfiram in treating alcohol dependence

1 reference

12 December 2020

A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence

1 reference

12 December 2020

Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats

1 reference

12 December 2020

Double-blind clinical trial of sertraline treatment for alcohol dependence

1 reference

12 December 2020

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

1 reference

12 December 2020

Impairment in memory function and neurodegenerative changes in the cholinergic basal forebrain system induced by chronic intake of ethanol

1 reference

12 December 2020

Naltrexone treatment of comorbid alcohol and cocaine use disorders

1 reference

12 December 2020

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

1 reference

12 December 2020

Alcoholism and the dopaminergic system: a review

1 reference

12 December 2020

Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?

1 reference

12 December 2020

The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction

1 reference

12 December 2020

The role of GABA(A) receptors in the acute and chronic effects of ethanol.

1 reference

12 December 2020

Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics

1 reference

12 December 2020

The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area.

1 reference

12 December 2020

Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol

1 reference

12 December 2020

Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial

1 reference

12 December 2020

Naltrexone in the treatment of alcohol dependence

1 reference

12 December 2020

Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study

1 reference

12 December 2020

Acamprosate treatment in a long-term community-based alcohol rehabilitation programme.

1 reference

12 December 2020

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence

1 reference

12 December 2020

A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment

1 reference

12 December 2020

Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting

1 reference

12 December 2020

Obsessive and compulsive characteristics of craving for alcohol in alcohol abuse and dependence

1 reference

12 December 2020

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

12 December 2020

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate

1 reference

12 December 2020

Tiapride in the prevention of relapse in recently detoxified alcoholics

1 reference

12 December 2020

Neurobiology of alcohol abuse

1 reference

12 December 2020

Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain

1 reference

12 December 2020

Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism

1 reference

12 December 2020

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

1 reference

12 December 2020

Alcohol consumption in rats treated with lithium carbonate or rubidium chloride

1 reference

12 December 2020

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

1 reference

12 December 2020

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

1 reference

12 December 2020

Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol

1 reference

12 December 2020

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial

1 reference

12 December 2020

Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism

1 reference

12 December 2020

[Acamprosate--a stabilizing factor in long-term withdrawal of alcoholic patients]

1 reference

12 December 2020

The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior

1 reference

12 December 2020

5-HT and alcohol abuse

1 reference

12 December 2020

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics

1 reference

12 December 2020

Opioid antagonists for alcohol dependence.

1 reference

12 December 2020

Tiapride in the long-term management of alcoholics of anxious or depressive temperament.

1 reference

12 December 2020

Comparison of acamprosate and placebo in long-term treatment of alcohol dependence

1 reference

12 December 2020

Interactions of serotonin with ethanol: clinical and animal studies

1 reference

12 December 2020

Influence of age, alcohol consumption and abstinence on the sensitivity of carbohydrate-deficient transferrin, gamma-glutamyltransferase and mean corpuscular volume.

1 reference

12 December 2020

Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study

1 reference

12 December 2020

Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects

1 reference

12 December 2020

Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multicenter trial. Ritanserin in Alcoholism Work Group.

1 reference

12 December 2020

Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial

1 reference

12 December 2020

Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.

1 reference

12 December 2020

Review and discussion of statistical analysis of controlled clinical trials in alcoholism.

1 reference

12 December 2020

Buspirone Treatment of Anxious Alcoholics

1 reference

12 December 2020

Alcohol treatment, changes in coping skills, self-efficacy, and levels of alcohol use and related problems 1 year following treatment initiation

1 reference

12 December 2020

The central basis of motivation: intracranial self-stimulation studies

1 reference

12 December 2020

Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment

1 reference

12 December 2020

Ethanol and neurotransmitter interactions--from molecular to integrative effects.

1 reference

12 December 2020

Naltrexone's effect on cue-elicited craving among alcoholics in treatment.

1 reference

12 December 2020

Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics

1 reference

12 December 2020

Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.

1 reference

12 December 2020

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

1 reference

12 December 2020

Effect of Fluoxetine on Alcohol Consumption in Male Alcoholics

1 reference

12 December 2020

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

1 reference

12 December 2020

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

1 reference

12 December 2020

Carbamazepine and ethanol elicited responses in rodents

1 reference

12 December 2020

Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

1 reference

12 December 2020

Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence.

1 reference

12 December 2020

Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies.

1 reference

12 December 2020

Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence

1 reference

12 December 2020

Lithium treatment of depressed and nondepressed alcoholics.

1 reference

12 December 2020

Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial

1 reference

12 December 2020

Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone)

1 reference

12 December 2020

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

1 reference

12 December 2020

Naltrexone in the treatment of alcohol dependence

1 reference

12 December 2020

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse

1 reference

12 December 2020

Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification

1 reference

12 December 2020

Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey

1 reference

12 December 2020

Sertraline for the prevention of relapse in detoxicated alcohol dependent patients with a comorbid depressive disorder: a randomized controlled trial

1 reference

12 December 2020

Predictors of compliance with naltrexone among alcoholics.

1 reference

12 December 2020

Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study.

1 reference

12 December 2020

Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes

1 reference

12 December 2020

Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome

1 reference

12 December 2020

1 reference

12 December 2020

10.2165/00023210-200418080-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

27 June 2017

1052320653

0 references

1 reference